<p>Professor Andrew Tutt is a Consultant Clinical Oncologist in the Breast Cancer Unit at Guy's and St Thomas' NHS Foundation Trust. He is also a Professor of Oncology at King's College in London.</p><p>We spoke to him about biomarkers for hormone therapy resistance and deficiency, and also on targeting the Achilles heel in BRCA1 and BRCA2 gene mutations.</p>

Professor Andrew Tutt is a Consultant Clinical Oncologist in the Breast Cancer Unit at Guy's and St Thomas' NHS Foundation Trust. He is also a Professor of Oncology at King's College in London. We spoke to him about biomarkers for hormone therapy resistance and deficiency, and also on targeting the Achilles heel in BRCA1 and BRCA2 gene mutations.

Cracking the Code: Biomarkers and the Fight Against Hormone Therapy Resistance

Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand, with a commitment to exploring and finding better treatments for people affected by breast cancer through clinical trials research. The Breast Cancer Trials Podcast is a platform to share the latest in breast cancer research, to share stories and experiences of those who have had breast cancer, and to help explain topics around breast cancer and clinical trials research. www.breastcancertrials.org.au

Share Cracking the Code: Biomarkers and the Fight Against Hormone Therapy Resistance

Sign up to save your podcasts

Cracking the Code: Biomarkers and the Fight Against Hormone Therapy Resistance

Cracking the Code: Biomarkers and the Fight Against Hormone Therapy Resistance